Linspec 50/100 mg/ml Solution for injection for dogs, cats, pigs and pre-ruminant calves

국가: 아일랜드

언어: 영어

출처: HPRA (Health Products Regulatory Authority)

유효 성분:

Lincomycin hydrochloride; Spectinomycin sulfate tetrahydrate

제공처:

Chanelle Pharmaceuticals Manufacturing Limited

ATC 코드:

QJ01FF52

INN (International Name):

Lincomycin hydrochloride; Spectinomycin sulfate tetrahydrate

복용량:

50, 100 milligram(s)/millilitre

약제 형태:

Solution for injection

처방전 유형:

POM: Prescription Only Medicine as defined in relevant national legislation

치료 그룹:

Cats, Cattle, Dogs, Pigs

치료 영역:

lincomycin, combinations

치료 징후:

Antibacterial

승인 상태:

Authorised

승인 날짜:

2010-07-29

제품 특성 요약

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Linspec 50/100 mg/ml Solution for injection for dogs, cats, pigs and
pre-ruminant calves
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Solution for injection.
Clear colourless solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle (pre-ruminating calves), Pigs, dogs and cats.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of respiratory infections, intestinal infections, urinary
tract infections, skin infections (including wounds and
abscess) and arthritis caused by organisms sensitive to lincomycin and
/ or spectinomycin including:
_Actinobacillus_ spp.
_Pasteurella_ spp.
_Brachyspira hyodysenteriae_
_Escherichia coli_
_Salmonella_ spp.
_Campylobacter_ spp.
_Bacteroides_ spp.
_Clostridium_ spp.
_Fusobacterium_ spp.
_Actinomyces_ spp.
_Staphylococcus_ spp.
_Streptococcus_ spp.
_Mycoplasma_ spp.
4.3 CONTRAINDICATIONS
Do not use in case of known hypersensitivity to the active substances
or to any of the excipients.
Do not
administer to rabbits,
hamsters,
guinea pigs,
chinchillas,
horses or ruminants as this could result
in severe
gastro-intestinal disturbance.
Each ml contains:
ACTIVE SUBSTANCE
Lincomycin (as lincomycin hydrochloride)
50
mg
Spectinomycin (as spectinomycin sulfate tetrahydrate) 100 mg
EXCIPIENTS
Benzyl alcohol (E1519)
9
mg
For the full list of excipients, see section 6.1.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_5_
_/_
_0_
_9_
_/_
_2_
_0_